| 144.52 -0.45 (-0.31%) | 04-17 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 179.49 | 1-year : | 192.7 |
| Resists | First : | 153.67 | Second : | 164.99 |
| Pivot price | 148.55 |
|||
| Supports | First : | 135.38 | Second : | 112.63 |
| MAs | MA(5) : | 146.03  |
MA(20) : | 151.62 |
| MA(100) : | 160.51 |
MA(250) : | 167.4 |
|
| MACD | MACD : | -4.5 |
Signal : | -4.2 |
| %K %D | K(14,3) : | 42 |
D(3) : | 43.6 |
| RSI | RSI(14): 38.8 |
|||
| 52-week | High : | 183.63 | Low : | 135.38 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ BBH ] has closed above bottom band by 32.5%. Bollinger Bands are 95.5% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 9 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 145.5 - 146.37 | 146.37 - 147.02 |
| Low: | 141.73 - 142.9 | 142.9 - 143.78 |
| Close: | 142.98 - 144.71 | 144.71 - 145.99 |
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Mon, 03 Mar 2025
7 Best-Performing Biotech ETFs for March 2025 - NerdWallet
Tue, 25 Feb 2025
Should You Invest in the VanEck Biotech ETF (BBH)? - Nasdaq
Fri, 20 Dec 2024
VanEck Announces Year-End Distributions for VanEck Equity ETFs - Business Wire
Fri, 28 Jun 2024
7 Best Biotech ETFs to Buy Now | Investing | U.S. News - Money/ US News
Wed, 31 May 2023
Should You Invest in the VanEck Biotech ETF (BBH)? - Yahoo News Singapore
Tue, 30 May 2023
Bevy of Biotech Bargains in BBH - ETF Trends
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|